Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Interventions
- Other: Task Oriented rehabilitation and aerobic training
- Registration Number
- NCT02960984
- Lead Sponsor
- Fondazione Don Carlo Gnocchi Onlus
- Brief Summary
In Multiple Sclerosis the multiplicity of physical and psychological dysfunctions have been shown to exhibit a number of life-altering problems such as fatigue, limb weakness, alteration of upper extremity fine motor coordination, loss of sensation, spasticity. These problems affect performance of many daily living activities (ADL) such as dressing, bathing, self-care, and writing, thus reducing functional independence and self-rated quality of life.
Twenty people with Multiple Sclerosis will receive neurorehabilitation treatment comprising a combination of aerobic training and upper limb task-oriented training.
The aim of this pilot crossover study is to evaluate the effects of neurorehabilitation on upper limb performance and on fatigue in People with Multiple Sclerosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- Diagnosis of Multiple Sclerosis
- no relapses in the last three months
- Expanded Disability Status Scale (EDSS) ≤ 8;
- subjects with relapses
- worsening of the pathology in the last three months
- subjects with cognitive and psychiatric disturbances
- subjects with cardiovascular disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Neurorehabilitation Task Oriented rehabilitation and aerobic training Participants in the experimental group will receive 1 hour treatment comprising 30' of aerobic training on an ergometer and 30' of task-oriented training focused on uppper limb rehabilitation.
- Primary Outcome Measures
Name Time Method Change from Baseline in Heart Rate at 2 and 4 months baseline, then participants were followed for the duration the outpatient treatment protocol, an average of 8 weeks, and at follow up 2 months after the end of the treatment protocol Change from Baseline in 9-hole peg test at 2 and 4 months baseline, then participants were followed for the duration the outpatient treatment protocol, an average of 8 weeks, and at follow up 2 months after the end of the treatment protocol
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Fondazione Don Gnocchi ONLUS
🇮🇹Milan, Italy